Early outcome in endovascular management of iliac artery
Abstract
Background: Peripheral arterial disease (PAD) considered one of the most important health problems due to functional disability, high morbidity and mortality associated with critical ischemia. There is a n important evidence support the safety and effectiveness of endovascular treatment in patients with iliac occlusive disease.
Objective: the study aimed to evaluate the early outcome of endovascular management (stenting) in patients with iliac occlusive disease. In addition to, determining the rate of primary patency and complications resulting of the procedure.
Patients and methods: a prospective observational analytic study conducted for one-year period (1/1/2020 – 31/12/2020) at Tichreen University Hospital in Lattakia – treatment (stenting).
Result: mean age was 57.5±5.8 (56.3% males, 34.7% females). Ankle-Brachial Index (ABI) ranged from 0.73 to 0.95 pre-procedure with mean value 0.66±0.03. According to Rutherford classification, 66.3% of patients were group 3. The lesion located in common iliac artery in 62.7% of the patients, external iliac artery in 37.3%. There was a significant increasing in ABI value after stenting (42.4%). One-year patency was 94.7%, while 4 patients (5.3%) represent occlusion. There were no local complications or mortality.
Conclusion: Management of iliac occlusive lesions by endovascular stenting considered as an effective safe method.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.